Daniel Ferguson

2.2k citations
28 papers · 1.8k · 2 hit papers · h-index 16

Impact in

    • Lipid metabolism and biosynthesis
    • Liver Disease Diagnosis and Treatment
    • Adipokines, Inflammation, and Metabolic Diseases

Papers in

    • Lipid metabolism and biosynthesis 5
    • Liver Disease Diagnosis and Treatment 7
    • Adipokines, Inflammation, and Metabolic Diseases 5

Daniel Ferguson

28 papers receiving 1.8k citations

Daniel Ferguson's Hit Papers

Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus 2021 · 386 citations
3860+3+7Years since publication100200300

Peers

Daniel Ferguson
Comparison fields: 5 of 86
  • Biochemistry 115
  • Epidemiology 432
  • Molecular Biology 701
  • Rheumatology 145
  • Endocrinology, Diabetes and Metabolism 117
Replace Xabier Buqué with:
Xabier Buqué Spain
Battsetseg Batchuluun Canada
Raquel Fucho Spain
Amanda L. Brown United States
Katarina Marcinko Canada
Maud Soty France
Javier Pizarro‐Delgado Spain
Nadia Panera Italy
Weibin Zha China
Antonio Martín‐Duce Spain
Daniel Ferguson relative to Xabier Buqué Spain Xabier Buqué's profile →
Citations per field
00.5×1.5×2.0×
Xabier Buqué · 1×
Citations per year

Countries citing papers authored by Daniel Ferguson

Since Specialization
Citations

This map shows the geographic impact of Daniel Ferguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ferguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ferguson more than expected).

Fields of papers citing papers by Daniel Ferguson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Ferguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ferguson. The network helps show where Daniel Ferguson may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Ferguson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Ferguson Line = papers co-authored together Daniel Ferguson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
Hit paper breakdown →
2021386
2
The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance
Hit paper breakdown →
2015360
3 2017254
4 2020151
5 2013114
6 2017103
7 202255
8 201642
9 202338
10 201735
11 202232
12 201630
13 202130
14 201924
15 202321
16 201717
17 202016
18 201812
19 202410
20 20219

About Daniel Ferguson

Daniel Ferguson is a scholar working on Biochemistry, Epidemiology, Molecular Biology, Physiology and Hepatology, having authored 28 papers that have together received 1.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), Metabolism, Diabetes, and Cancer (6 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers), Lipid metabolism and biosynthesis (5 papers), Adipose Tissue and Metabolism (4 papers), Gut microbiota and health (3 papers), Lipid metabolism and disorders (2 papers) and Osteoarthritis Treatment and Mechanisms (2 papers). The work is most often cited by research in Biochemistry (115 citations), Epidemiology (432 citations), Molecular Biology (701 citations), Rheumatology (145 citations) and Endocrinology, Diabetes and Metabolism (117 citations). Daniel Ferguson has collaborated with scholars based in United States, China and Austria. Frequent co-authors include Brian N. Finck, Charles Andrew Harris, Irina Hutson, Gretchen A. Meyer, Kyle S. McCommis, Farshid Guilak, Kelsey H. Collins, Arin K. Oestreich, Ruhang Tang and Kristin L. Lenz. Their work appears in journals such as Cell Reports, Endocrinology, Biochemical and Biophysical Research Communications, Journal of Clinical Investigation and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact